Interstitial lung disease in a newborn affected by mevalonic aciduria by S. Torreggiani et al.
P2034
Patient with FMF presented by isolated myositis
Sema N. Taskin, Aysenur Kisaarslan, Sümeyra Ozdemir Çiçek, Nihal Sahin,
Muammer Hakan Poyrazoğlu, Ruhan Dusunsel
Pediatric Rheumatology, Erciyes University Medical Faculty, Kayseri,
Turkey
Correspondence: Sema N. Taskin
Pediatric Rheumatology 2019, 17(Suppl 1):P2034
Introduction: Familial Mediterranean fever (FMF) is a genetic disease
characterized by recurrent febrile episodes and mostly by the inflam-
mation of serous membranes. We presented our case whom pre-
sented with acute myositis and was diagnosed as FMF.
Results: A six year and 5 mounth old girl complained of severe pain
in her right leg and a gait while walking for a period of one week. It
was learned from the history that the right ankle swelled and hipere-
mic macular rash were determined on lateral malleol area three years
ago and the acute phase reactants were elevated at that time.There
was no consanguinity and family history of autoinflammatory dis-
eases. Physical examination of the patient revealed swelling, redness,
thenderness, heat increase of on the calf muscles and limitation of
extension of the knee joint. White blood cells, C-reactive protein
(CRP), and eritrocyte sedimantation rate (ESR) were eleveated, muscle
enzymes were normal levels.In the USG, the right popliteal fossa fat
tissue was prominent and inflamed, and the neural structures were
thick and edematous.Magnetic Resonance imaging of the thighs and
right leg posterolateral muscles was consistent with myositis. After
NSAID treatment, the clinic improved. However, the high CRP and
ESR persisted for six mounths. There was no mutation on TRAPS
gene. When the M694V homozygous mutation was detected in the
FMF genetics of the patient, Familial Mediterranean Fever was diag-
nosed and colchicine treatment was started. Other autoinflammatory
diseases genes could not studied. Acute phase reactans of the pa-
tient regressed after the treatment. The patient experienced arthritis
attack at once for two years follow up.
Conclusion: The patients who carried M694V homozygous mutations
may presented nonclassical findings of FMF.
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Introduction: Mevalonic aciduria (MA) is the most severe phenotype
of mevalonate-kinase deficiency (MKD), with a onset in early infancy
and poor prognosis. MA diagnosis may be challenging in the neo-
natal period given its rarity and its unspecific symptoms that fre-
quently recall those of other neonatal diseases. To our knowledge,
interstial lung involvement has never been described as onset fea-
ture in a newborn with MKD.
Objectives: We report the case of a newborn affected by MKD char-
acterized by interstitial lung disease.
Methods: The patient underwent laboratory and radiology evaluation
as clinically indicated. Direct Sanger sequencing was used to screen
the 10 exons of the MVK gene.
Results: A female neonate born at term from consanguineous par-
ents was referred to our hospital at 16 days of life (DOL) for mild
hypotonia and persistent raised inflammatory markers despite anti-
biotic therapy. Infectious work-up was negative for both viral and
bacterial infections. Chest x-ray revealed bilateral perihilar peribron-
chial thickening. Electroencephalography (EEG) reported moderate
diffuse anomalies of background activity without major abnormal-
ities. On DOL 20 the first episode of fever was recorded. Due to wors-
ening tachypnea and persistent abnormal chest x-ray, a pulmonary
CT scan was performed and showed diffuse ground-glass bilateral in-
filtrates consistent with alveolar-interstitial lung disease. On DOL 22 a
palpable maculo-papular skin rash appeared on feet and hands, van-
ishing spontaneously 24 hours later. Bone marrow examination and
levels of perforins, neuron-specific enolase and urinary catabolites of
catecholamines were normal. A total body MRI was normal except
for a mild cerebellar hypoplasia and the known interstitial lung dis-
ease. The patient kept presenting hypotonia, relapsing episodes of
fever and skin rashes, developed anemia requiring blood transfusions
and failure to thrive became evident. Type-I IFN signature was nega-
tive. A genetic test was requested, as well as quantification of urinary
levels of mevalonic acid, which were markedly above the normal
range. Direct Sanger sequencing allowed to detect a homozygous
c.709A>T missense mutation in the exon 8 of the MVK gene, coding
for a protein substitution p.T237S already classified as pathogenic in
the INFEVERS database (http://fmf.igh.cnrs.fr/ISSAID/infevers/) and
therefore consistent with the diagnosis of MKD. Both parents and
her sister were found to be heterozygous carriers of the same muta-
tion. On DOL 38 treatment with anakinra was started, with prompt
regression of fever and skin rash, decrease in inflammatory markers,
increase in reticulocytes count and weight gain. Hypotonia improved
but persisted. The patient was discharged from hospital on DOL 56
in good clinical conditions, with acute phase reactants within the
normal range and mild hypotonia. She is now 4 months old, still on
anakinra treatment without adverse events.
Conclusion: Autoinflammatory diseases in the neonatal period are a
diagnostic challenge. Clinical suspicion is crucial in order to perform
specific laboratory and genetic testing and start appropriate treat-
ment. Interstitial lung involvement may be present in MKD and, to-
gether with increased inflammatory markers, could be the first
manifestation of the disease.
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Introduction: Familial Mediterranean Fever (FMF) is the most fre-
quent auto-inflammatory disease caused by MEFV gene mutations.
Although FMF is characterized by intermittent inflammatory attacks
some patients exert chronic persistent inflammation that can result
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